معرفی
Dr. Anna Zampetaki is a Senior Lecturer in Cardiovascular Biology at King's College London, affiliated with the School of Cardiovascular and Metabolic Medicine & Sciences. She leads research on molecular mechanisms of vascular injury/repair, focusing on metabolic pathways and regenerative medicine. Her work integrates organoid technologies, iPS cells, and gene editing to uncover therapeutic targets for vascular diseases.
Education details are not explicitly listed, but her career trajectory includes significant contributions to microRNA biology and vascular regeneration. Her research interests span vascular biology, metabolic influences on vascular health, and translational applications of organoid models.
Key research trends include the role of microRNAs (e.g., miR-126, miR-199a-3p) in vascular dysfunction, the application of blood vessel organoids to study diabetic vasculopathy, and leveraging CRISPR/Cas9 for understanding clustered miRNA regulation. Collaborations involve teams at King's College and international institutions.
No scientific awards are explicitly mentioned in the text. Teaching responsibilities include courses on vascular physiology, experimental cardiovascular research, and biomedical translational science. She oversees laboratory rotations and project supervision in molecular science and pharmacology.
The Zampetaki Lab actively develops vascular organoid models to study metabolic influences on microvascular integrity and diabetes-related vascular complications. Current projects include investigating CTGF's role in microvascular maintenance and exploring regenerative potential in cardiac tissues.
